What is CAI's five-year median EV/Sales?

5.6x. Half of CAI's weekly readings since May 2026 were higher and half were lower. This page has 26 weekly readings, from May 4, 2026 to Oct 26, 2026.

Does a low historical rank mean a stock is a buy?

No. The rank compares CAI only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.

Caris Life Sciences Inc (CAI) valuation history

Health Care

$35.82

Latest weekly close · Market cap $10.1B

Historically high

Caris Life Sciences' EV/Sales of 9.8x is higher than 98% of its weekly readings since May 2026 (as of Oct 29, 2026).

Forward P/E 96.3× (analyst estimates, not ranked).

Weekly EV/Sales since May 2026

EV/Sales each weekMiddle half of its readingsMedian 5.6×

Median: 5.6×
Low to high: 4.1× to 9.8×
Versus median: +77%
History starts: May 2026

EV/Sales

98thpercentile

of its weekly readings since May 2026

Growth, last 12 months vs the year before

Revenue: +85%
EPS: n/m

Price vs revenue and EPS, indexed to 100

Each line starts at 100 at its first positive reading over the last five years. Revenue and EPS change at fiscal quarter ends.

PriceRevenue, last 12 monthsEPS, last 12 months100 = first reading

EV/Sales at each year-end

The last weekly reading of each year, and its percentile against the five years before it.

No full calendar year of readings yet.

Health Care peers on EV/Sales

Each percentile compares a stock with its own last five years.

Compare CAI with peers

Health Care peers of CAI on EV/Sales
Stock	EV/Sales	Versus its own history	5-year percentile
ABBVAbbVie	8.7×	Historically high	100
AMGNAmgen	7.6×	Historically high	98
ARWRArrowhead Pharmaceuticals Inc	11.5×	Within its usual range	32
BBIOBridgebio Pharma Inc	22.2×	Below its usual range	30
BIIBBiogen	4.1×	Above its usual range	85

Appears in

Sector: Health Care
Screens: Nuclear Stocks: Valuation Screen
Semiconductor Equipment Stocks: Valuation Screen

Screen Health Care stocks the same way

Research on CAI

No articles about CAI yet. How valuation percentiles work

Loading peers and related research…

About this history

What is CAI's current EV/Sales?: Caris Life Sciences' EV/Sales of 9.8x is higher than 98% of its weekly readings since May 2026 (as of Oct 29, 2026).
What is CAI's five-year median EV/Sales?: 5.6x. Half of CAI's weekly readings since May 2026 were higher and half were lower. This page has 26 weekly readings, from May 4, 2026 to Oct 26, 2026.
Does a low historical rank mean a stock is a buy?: No. The rank compares CAI only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.